Guidelines

NACDS, WSPA and NCPA file legal brief in Washington’s Medicaid lawsuit
The National Association of Chain Drug Stores, Washington State Pharmacy Association and the National Community Pharmacists Association filed a key legal brief with the Washington State Court of Appeals that challenges the state’s refusal to reimburse community pharmacies for the cost of providing care and services to disadvantaged Medicaid patients.
CRN issues voluntary guidelines on SARMs, caffeine-infused supplements
In light of growing concerns on the dangers of products containing selective androgen receptor modulators (SARMs) and caffeine-containing dietary supplements, the Council for Responsible Nutrition announced on Thursday that it has issued new voluntary guidelines.

PQS’ EQuIPP now represents 3-in-4 Medicare patients

As it surpasses this milestone, Pharmacy Quality Solutions said its EQuIPP platform would soon feature more performance measures, including expanded measure sets aimed at adherence for such categories as asthma inhalers, antidepressants and antipsychotics.
Lupin, Mylan partner on global Enbrel biosimilar

The two companies will work together to commercialize Lupin’s biosimilar of Enbrel (etanercept), which it has already submitted for European Medicines Agency for approval.
FDA approves Aurobindo’s generic Invanz injection

The product will launch in July into a market with annual sales of $387 million for the 12 months ended April 2018, according to IQVIA data.
ANI launches generic Questran

The launch is part of ANI’s ongoing efforts to re-commercialize discontinued generics that the company recently acquired.
Rite Aid’s Idaho pharmacists will soon prescribe some meds

Rite Aid announced on Wednesday that, starting July 1, pharmacists at all locations in Idaho will be able to prescribe medications to treat select, common conditions like cold sores, seasonal influenza, strep throat and urinary tract infections, as well as statins for patients with diabetes.
MinuteClinic offers hep A vaccine amid Ohio outbreak

With Ohio’s health department reporting more than 80 cases of Hepatitis A since the beginning of the year, MinuteClinic is stepping up to offer the Hepatitis A vaccine to unvaccinated Ohioans.
Albertsons offers increased access to naloxone

More than 1,600 Albertsons Companies pharmacies across 21 states have pharmacists with the ability to independently provide naloxone, a medication used to reverse the impacts of an opioid overdose, and to educate patients and caregivers about its use, the retailer has announced.
Amneal, Actavis settle generic Rytary litigation

Under the settlement, Ameal will grant Actavis a license to sell its generic Rytary on July 31, 2025, or earlier under certain circumstances.

NACDS, WSPA and NCPA file legal brief in Washington’s Medicaid lawsuit

CRN issues voluntary guidelines on SARMs, caffeine-infused supplements

PQS’ EQuIPP now represents 3-in-4 Medicare patients

Lupin, Mylan partner on global Enbrel biosimilar

FDA approves Aurobindo’s generic Invanz injection

ANI launches generic Questran

Rite Aid’s Idaho pharmacists will soon prescribe some meds

MinuteClinic offers hep A vaccine amid Ohio outbreak

Albertsons offers increased access to naloxone

Amneal, Actavis settle generic Rytary litigation